PetMed Ebit Per Revenue from 2010 to 2025

PETS Stock  USD 4.42  0.12  2.79%   
PetMed Express Ebit Per Revenue yearly trend continues to be comparatively stable with very little volatility. Ebit Per Revenue is likely to outpace its year average in 2025. From the period from 2010 to 2025, PetMed Express Ebit Per Revenue quarterly data regression had mean square error of  0.01 and mean deviation of  0.07. View All Fundamentals
 
Ebit Per Revenue  
First Reported
2010-12-31
Previous Quarter
(0.03)
Current Value
(0.02)
Quarterly Volatility
0.08660861
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check PetMed Express financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PetMed Express' main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.5 M, Interest Expense of 3.6 M or Selling General Administrative of 66.7 M, as well as many indicators such as Price To Sales Ratio of 0.29, Dividend Yield of 0.12 or PTB Ratio of 1.08. PetMed financial statements analysis is a perfect complement when working with PetMed Express Valuation or Volatility modules.
  
Check out the analysis of PetMed Express Correlation against competitors.
For more information on how to buy PetMed Stock please use our How to Invest in PetMed Express guide.

Latest PetMed Express' Ebit Per Revenue Growth Pattern

Below is the plot of the Ebit Per Revenue of PetMed Express over the last few years. It is PetMed Express' Ebit Per Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in PetMed Express' overall financial position and show how it may be relating to other accounts over time.
Ebit Per Revenue10 Years Trend
Slightly volatile
   Ebit Per Revenue   
       Timeline  

PetMed Ebit Per Revenue Regression Statistics

Arithmetic Mean0.08
Coefficient Of Variation111.58
Mean Deviation0.07
Median0.12
Standard Deviation0.09
Sample Variance0.01
Range0.2984
R-Value(0.30)
Mean Square Error0.01
R-Squared0.09
Significance0.26
Slope(0.01)
Total Sum of Squares0.11

PetMed Ebit Per Revenue History

2025 -0.0248
2024 -0.0261
2023 -0.029
2022 -0.005567
2021 0.094
2018 0.16
2017 0.19

About PetMed Express Financial Statements

PetMed Express shareholders use historical fundamental indicators, such as Ebit Per Revenue, to determine how well the company is positioned to perform in the future. Although PetMed Express investors may analyze each financial statement separately, they are all interrelated. The changes in PetMed Express' assets and liabilities, for example, are also reflected in the revenues and expenses on on PetMed Express' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Ebit Per Revenue(0.03)(0.02)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for PetMed Stock Analysis

When running PetMed Express' price analysis, check to measure PetMed Express' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PetMed Express is operating at the current time. Most of PetMed Express' value examination focuses on studying past and present price action to predict the probability of PetMed Express' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PetMed Express' price. Additionally, you may evaluate how the addition of PetMed Express to your portfolios can decrease your overall portfolio volatility.